Drug Free Solution Stock Buy Hold or Sell Recommendation
| DSOL Stock | USD 0.0002 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Drug Free Solution is 'Not Rated'. The recommendation algorithm takes into account all of Drug Free's available fundamental, technical, and predictive indicators you will find on this site.
Check out Drug Free Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Drug and provide practical buy, sell, or hold advice based on investors' constraints. Drug Free Solution. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Drug |
Execute Drug Free Buy or Sell Advice
The Drug recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Drug Free Solution. Macroaxis does not own or have any residual interests in Drug Free Solution or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Drug Free's advice using the current market data and latest reported fundamentals.
Time Horizon
3 Months |
Risk Tolerance
I am an educated risk taker |
 |  |
Not Rated
Drug Free Trading Alerts and Improvement Suggestions
| Drug Free Solution generated a negative expected return over the last 90 days | |
| Drug Free Solution has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Drug Free until it has trouble settling it off, either with new capital or with free cash flow. So, Drug Free's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Drug Free Solution sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Drug to invest in growth at high rates of return. When we think about Drug Free's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (755.87 K) with loss before overhead, payroll, taxes, and interest of (171.22 K). | |
| Drug Free Solution currently holds about 7.12 K in cash with (692.31 K) of positive cash flow from operations. |
Drug Free Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Drug Free or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Drug Free's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Drug pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Drug Free Volatility Alert
At this time Drug Free Solution exhibits very low volatility. Drug Free Solution appears to be a penny stock. Although Drug Free Solution may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Drug Free Solution or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Drug instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Drug Free Fundamentals Vs Peers
Comparing Drug Free's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Drug Free's direct or indirect competition across all of the common fundamentals between Drug Free and the related equities. This way, we can detect undervalued stocks with similar characteristics as Drug Free or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Drug Free's fundamental indicators could also be used in its relative valuation, which is a method of valuing Drug Free by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Drug Free to competition |
| Fundamentals | Drug Free | Peer Average |
| Return On Asset | -12.7 | -0.14 |
| Operating Margin | (413.00) % | (5.51) % |
| Current Valuation | 496.08 K | 16.62 B |
| Shares Outstanding | 35.94 M | 571.82 M |
| Price To Earning | (1.56) X | 28.72 X |
| Price To Sales | 239.51 X | 11.42 X |
| Gross Profit | (171.22 K) | 27.38 B |
| EBITDA | (862.83 K) | 3.9 B |
| Net Income | (755.87 K) | 570.98 M |
| Cash And Equivalents | 7.12 K | 2.7 B |
| Current Ratio | 0.02 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (692.31 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Beta | -4.9 | -0.15 |
| Market Capitalization | 503.2 K | 19.03 B |
| Total Asset | 11.79 K | 29.47 B |
| Retained Earnings | (1.68 M) | 9.33 B |
| Working Capital | (384 K) | 1.48 B |
| Current Asset | 7 K | 9.34 B |
| Current Liabilities | 391 K | 7.9 B |
| Net Asset | 11.79 K |
Drug Free Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Drug . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 |
About Drug Free Buy or Sell Advice
When is the right time to buy or sell Drug Free Solution? Buying financial instruments such as Drug Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Drug Free in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.